A Study of FCX-007 for Recessive Dystrophic Epidermolysis Bullosa (RDEB)
Clinical trial NCT02810951 · TERMINATED
Trial details
- NCT number
- NCT02810951
- Sponsor
- Castle Creek Biosciences, LLC.
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-01
- Primary completion
- 2020-09-29
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.